AXGT - Axovant Gene Therapies Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20193/31/20183/31/20173/31/2016
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development87,552141,412134,77876,644
Selling General and Administrative39,46671,90645,72156,518
Non Recurring----
Others----
Total Operating Expenses127,018213,318180,499133,162
Operating Income or Loss-127,018-213,318-180,499-133,162
Income from Continuing Operations
Total Other Income/Expenses Net-1,914-7,334-1,512-
Earnings Before Interest and Taxes-127,018-213,318-180,499-133,162
Interest Expense-7,530-7,545-1,143-1,143
Income Before Tax-128,932-220,652-182,011-133,162
Income Tax Expense133921-1,060-17
Minority Interest----
Net Income From Continuing Ops-129,065-221,573-180,951-133,145
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-129,065-221,573-180,951-133,145
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-129,065-221,573-180,951-133,145